Agreement

RNS Number : 4386L

Microsaic Systems plc

04 September 2012

 



Microsaic Systems plc

("Microsaic" or the "Company")

Microsaic's International Partner to present its new Mass Directed Flash System at JASIS 2012

4 September 2012 

Microsaic Systems plc (AIM: MSYS),  today announces that Biotage AB (Uppsala, Sweden), a leading global supplier of laboratory equipment, will be presenting its fully integrated solution for 'Mass Directed Flash' purification at JASIS 2012 (Japan Analytical Scientific Instruments Show) in Makuhari Messe, Japan (5-7 September). This is the first time Biotage has presented the new system, which incorporates Microsaic's novel miniature mass spectrometer - the Microsaic MiD.

Microsaic entered an agreement in May 2012 with Biotage, previously identified in announcements as 'an international supplier of laboratory equipment',to provide its MiD chip-based scientific instrument as an Original Equipment Manufacturer (OEM). Since then, Microsaic has further developed the MiD and the companies are at an advanced stage of integrating it with Biotage's flagship Flash purification system Isolera™. The new integrated system is expected to be commercially available in early 2013.

Mass directed flash purification is a powerful technique for collecting compounds based on mass allowing the chemist to purify and analyse compounds at the same time.

Eric Yeatman, Chief Executive of Microsaic Systems, commented:

"One of Microsaic's key strategic aims is to grow sales of our innovative products as an OEM partner with leading international suppliers of  scientific instruments in specified application areas of chemical separation and purification. Our objective is to benefit from access to an existing customer base and also to make mass spectrometry available to a wide range of new customers and to open new opportunities. We are very pleased at the progress being made with Biotage, which matches unique benefits of our miniaturised instruments with their product development and international commercial capabilities."

Toshiyuki Yachi, Vice President Marketingof Biotage, added:

"This is a game changer in flash purification that will allow chemists to significantly improve their work flow. We have high expectations on the forthcoming launch of this product that will further strengthen our purification business."

Contacts

Microsaic Systems Eric Yeatman, CEO	Via Citigate Dewe Rogerson
Numis Securities Limited Stuart Skinner (Nominated Adviser) James Serjeant (Broker)	[phone]
Citigate Dewe Rogerson (Financial PR) Mark Swallow, Malcolm Robertson, Chris Gardner	[phone]/2948
The Scott Partnership (Trade PR) Sarah Evans	[phone]

About Microsaic Systems

Microsaic Systems develops chip-based scientific instruments for the identification of substances in solids, liquids and gases. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry (MS).

Microsaic Systems has developed a miniaturised mass spectrometer product, based on its patented, chip-based technologies (ionchip^®, spraychip^® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional MS systems.

Mass spectrometry (MS) is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world's top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 272 employees with sales of 428.4 MSEK in 2011. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com 

 

END

 

 

MSCGIGDCSSGBGDS